Island Pharmaceuticals (ASX:ILA)
Company Profile
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Island Pharmaceuticals.
RELATED STOCKHEAD STORIES
Health Check: Telix shares rocket after bullish quarterly sales update
Island phase 2a/b mosquito-borne dengue fever results due in May
Lunch Wrap: ASX volatile as Nasdaq smashed; MinRes tumbles 7pc after haul road mishap
Major Singaporean and Hong Kong investors bet on ASX healthcare’s upside
Island completes dosing in phase 2b arm of mosquito-borne dengue trial
Health Check: With a US military win, Bio-Gene declares germ warfare on mosquitos, ticks and bed bugs
Closing Bell: Iron ore miners hammered, but Trump’s Canada tariffs boost uranium stocks
Island completes phase 2b enrolments in dengue fever trial
Road to 2025: Clinical trials hit fever pitch for Island Pharmaceuticals
Long Shortz with Island Pharmaceuticals: Phase 2b trial into dengue fever kicks off
Health Check: Which stock just dumped 19% on earnings downgrade?
Island Pharmaceuticals starts phase 2b dengue trial
Long Shortz with Island Pharmaceuticals: Trial success with dengue fever drug
